Stock Analiz

Adagio Medical Holdings, Inc. ADGM

Medical/Dental Instruments · data as of November 13, 2026

$1.93Market cap $53M
Open the interactive analysis →

Adagio Medical Holdings, Inc. (ADGM) is a healthcare company listed in the US with a market value of about $53M.

Its overall Stock Analiz score is 0.0 out of 5 (weak). The strongest part is value (0/5); the weakest is value (0/5).

Key numbers: a 5-year average ROIC of -64%.

About Adagio Medical

Adagio Medical is listed in the US and classified in medical/dental instruments. It was profitable in 0 of the last 2 years in our data.

Score: 0.0 / 5

Value0/5
Future growth0/5
Track record0/5
Financial health0/5
Shareholder returns0/5

Checks passed

  • —

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Profit margin improving

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S—
P/B—
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield-31.3%
Shareholder yield0.0%
Intrinsic value vs. price—

Growth and quality

Revenue growth (1 yr)-100.0%
Revenue growth (5 yrs, per year)—
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-12196.7%
ROIC (5-yr avg.)-64.1%
Profitable years (of last 10)0
Years paying a dividend—

Financials, last 2 years

Fiscal year20252023
Revenue$0$300000
Net income-$25M-$37M
Free cash flow-$19M-$26M
EPS (diluted)$-1.51$-48.16
Net margin—-12196.7%
ROIC-64.1%—

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

Does Adagio Medical pay a dividend?

Not currently.

Is Adagio Medical a good stock to buy?

We do not give buy or sell advice. Adagio Medical scores 0.0 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.